secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexaria Bioscience Corp. (LEXX)
CIK:        0001348362
Form:       8-K
Filed at:   2023-06-12T23:59:59+00:00
Accession:  0001640334-23-001035
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Lexaria Bioscience dismisses CFO Gregory Downey; CEO assumes principal financial officer role
--------------------------------------------------------------------------------

- Gregory Downey dismissed as CFO effective June 6, 2023; company actively seeking replacement.
- Interim CFO services provided by Mike Shankman of NOW CFO; Shankman is CPA with MBA, healthcare experience.
- CEO Chris Bunka assumes role of principal financial officer; no additional compensation for Bunka.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348362/000164033423001035/0001640334-23-001035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348362/000164033423001035/lxrp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-23-001035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer